Harnessing Immuno-nanotechnology for Therapy of Inflammatory Bowel Disease.

Epigenetic Control of Intestinal Inflammation.

Is Restricted Expression of TLR5 in the Small Intestine Necessary to Limit Responses to Commensal Bacteria?

Novel Adhesive Interactions Modulate T Cell Responses In IBD.

From Newborn Immunity To Adult IBD.

The Role Of Long Non-Coding RNA, LincRNA-Eps In Controlling Gut Inflammation.

The Role of Mycobiota During Immunomodulatory Therapy For Inflammatory Bowel Disease.

Learning From Mother Nature: Exploring Complex Sugars in Mother’s Milk as New, Safe and Effective IBD Interventions.

The Role of Mycobiota During Immunomodulatory Therapy For Inflammatory Bowel Disease.

Exploring the Interaction of the IBD Virome With Innate Immune Sensors, RIG-I And MDA-5.